Option Care Health to Participate in the TD Cowen Healthcare Conference

Option Care Health (Nasdaq: OPCH) will participate in the 46th Annual TD Cowen Healthcare Conference in Boston on Tuesday, March 3, 2026, including a fireside chat at 1:10 PM ET.

Rhea-AI Summary

Option Care Health (Nasdaq: OPCH) will participate in the 46th Annual TD Cowen Healthcare Conference in Boston on Tuesday, March 3, 2026, including a fireside chat at 1:10 PM ET. The company will webcast the presentation at its investor site.

Option Care Health is described as the nation’s largest independent provider of home and alternate site infusion services, with over 8,000 team members and more than 5,000 clinicians serving all 50 states.

Argus Jan 30 session

+0.32% close to close Open Argus

Details

News Market Reaction – OPCH

On Jan 30, the first trading day after this news, OPCH closed 0.32% above the previous close.

Data tracked by StockTitan Argus for the Jan 30 session.

Market Context

This announcement highlights Option Care Health’s participation in a major healthcare conference, co...

Analysis

This announcement highlights Option Care Health’s participation in a major healthcare conference, continuing a pattern of active investor engagement. Recent history shows a mix of solid operating performance, expanded repurchase authorization, and frequent conference appearances. Together, these updates emphasize scale, national reach, and capital allocation. Investors may focus on how upcoming presentations, the scheduled Feb 24, 2026 earnings release, and any updated guidance refine the company’s growth, margin, and cash flow trajectory over 2026 and beyond.

Key Figures

Conference edition: 46th Annual Conference date: March 3, 2026 Session time: 1:10pm ET +3 more

Conference edition

46th Annual

TD Cowen Healthcare Conference

Conference date

March 3, 2026

TD Cowen Healthcare Conference fireside chat

Session time

1:10pm ET

Fireside chat at TD Cowen Healthcare Conference

Team members

over 8,000

Total workforce across the U.S.

Clinicians

more than 5,000

Clinical staff supporting infusion services

States served

50 states

National coverage for home and alternate site infusion

Historical Context

5 past events · Latest: Jan 21

5 events

1. Jan 21

   Earnings date notice

   24h Move

   +0.9%

   Set timing and access details for upcoming Q4 and full-year 2025 results.

2. Jan 12

   Prelim earnings, guidance

   24h Move

   +0.8%

   Preliminary Q4 and 2025 results plus 2026 guidance and expanded buyback program.

3. Dec 12

   Conference participation

   24h Move

   +1.0%

   Participation in J.P. Morgan Healthcare Conference with webcasted presentation.

4. Nov 03

   Multiple conferences

   24h Move

   +1.5%

   Lineup of several investor conferences offering corporate updates and Q&A.

5. Oct 30

   Quarterly earnings

   24h Move

   -8.6%

   Q3 2025 revenue and adjusted metrics grew, but shares fell notably afterward.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BANNOCKBURN, Ill., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the 46th Annual TD Cowen Healthcare Conference, being held in Boston, MA, on Tuesday, March 3, 2026, including a fireside chat at 1:10pm ET. The webcast will be available online at https://investors.optioncarehealth.com.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.

For Investor Inquiries:

Nicole Maggio
Senior Vice President, Corporate Controller
Investor.relations@optioncare.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Option Care Health (OPCH) present at the TD Cowen Healthcare Conference?

Option Care Health will present on March 3, 2026, with a fireside chat at 1:10 PM ET. According to Option Care Health, the appearance is part of the conference schedule and will be available via webcast on the company's investor site.

How can investors watch Option Care Health's (OPCH) webcast from the TD Cowen conference?

Investors can watch the live webcast at https://investors.optioncarehealth.com. According to Option Care Health, the webcast will stream the fireside chat and any presentation materials the company provides during the March 3, 2026 session.

What will Option Care Health (OPCH) discuss at the TD Cowen Healthcare Conference fireside chat?

The company will present corporate updates and strategy during the fireside chat at 1:10 PM ET on March 3, 2026. According to Option Care Health, the session will cover its role as a national infusion services provider and related operational highlights.

Who is Option Care Health and what scale does OPCH report ahead of the March 3, 2026 presentation?

Option Care Health is the nation’s largest independent home and alternate site infusion services provider, with over 8,000 team members and more than 5,000 clinicians. According to Option Care Health, it operates across all 50 states.

Who should investors contact for inquiries about Option Care Health (OPCH) and the conference presentation?

Investor inquiries can be directed to Nicole Maggio, Senior Vice President, Corporate Controller, via the investor relations email. According to Option Care Health, contact details are provided for follow-up questions related to the March 3, 2026 presentation.